Cyclo-oxygenase-inhibitors increase morphine effects on mesolimbic dopamine neurons

European Journal of Pharmacology

Volumn 387, Issue 1, 2000, Pages R1-

  Melis, Miriam ^a   Diana, Marco ^b   Gessa, Gian Luigi ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

Dopamine; Electrophysiology; Morphine

Indexed keywords

INDOMETACIN; MORPHINE; NIMESULIDE; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG POTENTIATION; ELECTROPHYSIOLOGY; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SHORT SURVEY;

EID: 0033984335     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00799-2     Document Type: Article

References (8)

1. Cazala P. Dose-dependent effects of morphine differentiate self-administration elicited from lateral hypothalamus and mesencephalic central gray area in mice. Brain Res. 527:1990;280-285.
2. Diana M., Melis M., Muntoni A.L., Gessa G.L. Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proc. Natl. Acad. Sci. U.S.A. 95:1998;10269-10273.
3. Finnerty E.P., Chan S.H.H. Morphine suppression of substantia nigra zona reticulata neurons in the rat: implicated role for a novel striatonigral feedback mechanism. Eur. J. Pharmacol. 59:1979;307-310.
4. Franklin K.B.J. Analgesia and abuse potential: an accidental association or a common substrate? Pharmacol. Biochem. Behav. 59(4):1998;993-1002.
5. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12(2):1992;483-488.
6. Matthews R.T., German D.C. Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine. Neuroscience. 11(3):1984;617-625.
7. Vaughan C.W. Enhancement of opioid inhibition of GABAergic synaptic transmission by cyclo-oxygenase inhibitors in rat periaqueductal grey neurones. Br. J. Pharmacol. 123:1998;1479-1481.
8. Wise R.A. The role of reward pathways in the development of drug dependence. Pharmacol. Ther. 35:1987;227-263.